Stomach Vs. Thigh Vs. Arm: What the Clinical Data Really Says About Wegovy Injection Sites

Breaking down the facts behind Stomach Vs. Thigh Vs. Arm: What the Clinical Data Really Says About Wegovy Injection Sites—uncover the essential highlights.

While debating stomach versus thigh, many patients ignore a far more consequential practice: systematic site rotation. Injecting the medication into the exact same patch of skin every seven days causes chronic localized trauma. Over months of therapy, this habit leads directly to lipohypertrophy, a condition where subcutaneous fat cells swell and form dense, fibrous rubbery lumps under the skin.

Lipohypertrophic tissue alters drug kinetics dramatically. Injecting into an area of chronic scarring or fat hypertrophy unpredictably delays semaglutide absorption rate or traps the peptide locally, leading to erratic blood levels. A patient might find their appetite surging unexpectedly one week, followed by overwhelming nausea the next, purely because scarred subcutaneous tissue released the medication unevenly.

Proper rotation does not require switching from the belly to the leg every week. Instead, patients using the abdomen should picture four distinct quadrants around the navel, staying at least two inches away from the belly button itself. Moving clockwise each week ensures that any given entry point receives roughly three to four weeks of total recovery time. This discipline prevents bruising and skin irritation, minimizes localized injection site reactions, and preserves healthy tissue architecture for long-term treatment.